D-0233-2022 Class II Terminated

Recalled by Amneal Pharmaceuticals Of New York, LLC — Brookhaven, NY

FDA drug recall D-0233-2022 was initiated by Amneal Pharmaceuticals Of New York, LLC on Nov 4, 2021 and is designated Class II. Reason for recall: Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide. The recall status is terminated (terminated Jun 9, 2022). Affected quantity: 7,766 bottles.

Recall details

Product Type
Drugs
Report Date
Nov 24, 2021
Initiation Date
Nov 4, 2021
Termination Date
Jun 9, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
7,766 bottles

Product description

Flocinolone Acetonide 0.01% Topical Oil, Body Oil, Rx, packaged in 4 oz. bottle, Distributed by: Amneal Pharmaceuticals Bridgewater, NJ 08807, NDC 65162-704-86

Reason for recall

Subpotent Drug: Out-of-specification assay result was obtained for Fluocinolone Acetonide.

Distribution pattern

Product was distributed nationwide within the United States

Code information

Lot #: 07040001A, exp. date 02/2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0233-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0233-2022. Report a data issue: hello@regdatalab.com.